vs
Assertio Holdings, Inc.（ASRT）与FiscalNote Holdings, Inc.（NOTE）财务数据对比。点击上方公司名可切换其他公司
FiscalNote Holdings, Inc.的季度营收约是Assertio Holdings, Inc.的1.6倍（$22.2M vs $13.5M），FiscalNote Holdings, Inc.同比增速更快（-24.7% vs -57.9%），过去两年FiscalNote Holdings, Inc.的营收复合增速更高（-16.8% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
FiscalNote Holdings, Inc.（常称FiscalNote）是一家上市的软件数据与传媒企业，总部位于美国华盛顿特区，2013年由三位创始人创立。核心业务为通过政府关系管理服务FiscalNote GRM提供软件工具、平台、数据服务与资讯，同时依托人工智能平台分析美国待审议法案相关内容。
ASRT vs NOTE — 直观对比
营收规模更大
NOTE
是对方的1.6倍
$13.5M
营收增速更快
NOTE
高出33.3%
-57.9%
两年增速更快
NOTE
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $22.2M |
| 净利润 | — | — |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | -83.7% |
| 净利率 | — | — |
| 营收同比 | -57.9% | -24.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-4.54 | $-2.81 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTNOTE
| Q4 25 | $13.5M | $22.2M | ||
| Q3 25 | $49.5M | $22.4M | ||
| Q2 25 | $29.2M | $23.3M | ||
| Q1 25 | $26.5M | $27.5M | ||
| Q4 24 | $32.2M | $29.5M | ||
| Q3 24 | $29.2M | $29.4M | ||
| Q2 24 | $31.1M | $29.2M | ||
| Q1 24 | $32.4M | $32.1M |
净利润ASRTNOTE
| Q4 25 | — | — | ||
| Q3 25 | $11.4M | $-24.9M | ||
| Q2 25 | $-16.4M | $-13.3M | ||
| Q1 25 | $-13.5M | $-4.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.9M | $-14.9M | ||
| Q2 24 | $-3.7M | $-12.8M | ||
| Q1 24 | $-4.5M | $50.6M |
营业利润率ASRTNOTE
| Q4 25 | -86.7% | -83.7% | ||
| Q3 25 | 23.2% | -43.4% | ||
| Q2 25 | -27.5% | -31.9% | ||
| Q1 25 | -50.0% | -50.0% | ||
| Q4 24 | -41.9% | -19.4% | ||
| Q3 24 | -10.4% | -23.1% | ||
| Q2 24 | -11.6% | -27.2% | ||
| Q1 24 | -13.4% | -35.6% |
净利率ASRTNOTE
| Q4 25 | — | — | ||
| Q3 25 | 23.1% | -110.8% | ||
| Q2 25 | -56.0% | -57.0% | ||
| Q1 25 | -51.1% | -15.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -10.0% | -50.7% | ||
| Q2 24 | -11.8% | -43.6% | ||
| Q1 24 | -13.9% | 157.6% |
每股收益（稀释后）ASRTNOTE
| Q4 25 | $-4.54 | $-2.81 | ||
| Q3 25 | $0.11 | $-1.73 | ||
| Q2 25 | $-0.17 | $-0.08 | ||
| Q1 25 | $-0.14 | $-0.03 | ||
| Q4 24 | $-3.28 | $1.88 | ||
| Q3 24 | $-0.03 | $-1.33 | ||
| Q2 24 | $-0.04 | $-0.09 | ||
| Q1 24 | $-0.05 | $0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $26.3M |
| 总债务越低越好 | — | $128.4M |
| 股东权益账面价值 | $94.0M | $62.0M |
| 总资产 | $267.0M | $255.1M |
| 负债/权益比越低杠杆越低 | — | 2.07× |
8季度趋势，按日历期对齐
现金及短期投资ASRTNOTE
| Q4 25 | $63.4M | $26.3M | ||
| Q3 25 | $93.4M | $31.2M | ||
| Q2 25 | $98.2M | $38.5M | ||
| Q1 25 | $87.3M | $46.3M | ||
| Q4 24 | $100.1M | $34.6M | ||
| Q3 24 | $88.6M | $32.7M | ||
| Q2 24 | $88.4M | $37.7M | ||
| Q1 24 | $80.7M | $43.6M |
总债务ASRTNOTE
| Q4 25 | — | $128.4M | ||
| Q3 25 | — | $131.5M | ||
| Q2 25 | — | $116.7M | ||
| Q1 25 | — | $118.0M | ||
| Q4 24 | — | $147.1M | ||
| Q3 24 | — | $152.2M | ||
| Q2 24 | — | $145.9M | ||
| Q1 24 | $38.6M | $153.0M |
股东权益ASRTNOTE
| Q4 25 | $94.0M | $62.0M | ||
| Q3 25 | $105.8M | $75.5M | ||
| Q2 25 | $93.3M | $95.1M | ||
| Q1 25 | $108.5M | $98.7M | ||
| Q4 24 | $121.1M | $97.8M | ||
| Q3 24 | $130.5M | $98.5M | ||
| Q2 24 | $132.2M | $106.9M | ||
| Q1 24 | $134.5M | $106.1M |
总资产ASRTNOTE
| Q4 25 | $267.0M | $255.1M | ||
| Q3 25 | $319.8M | $273.9M | ||
| Q2 25 | $273.8M | $288.3M | ||
| Q1 25 | $286.4M | $299.7M | ||
| Q4 24 | $284.7M | $326.2M | ||
| Q3 24 | $276.0M | $337.9M | ||
| Q2 24 | $279.4M | $346.3M | ||
| Q1 24 | $282.0M | $357.8M |
负债/权益比ASRTNOTE
| Q4 25 | — | 2.07× | ||
| Q3 25 | — | 1.74× | ||
| Q2 25 | — | 1.23× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 1.50× | ||
| Q3 24 | — | 1.54× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | 0.29× | 1.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-279.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-1.9M |
| 自由现金流率自由现金流/营收 | — | -8.7% |
| 资本支出强度资本支出/营收 | — | 7.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-18.6M |
8季度趋势，按日历期对齐
经营现金流ASRTNOTE
| Q4 25 | $-30.0M | $-279.0K | ||
| Q3 25 | $-4.8M | $-8.3M | ||
| Q2 25 | $19.1M | $-6.2M | ||
| Q1 25 | $-12.5M | $3.3M | ||
| Q4 24 | $11.5M | $-1.3M | ||
| Q3 24 | $-35.0K | $-3.0M | ||
| Q2 24 | $7.4M | $-3.7M | ||
| Q1 24 | $7.5M | $2.7M |
自由现金流ASRTNOTE
| Q4 25 | — | $-1.9M | ||
| Q3 25 | — | $-10.4M | ||
| Q2 25 | — | $-7.7M | ||
| Q1 25 | — | $1.3M | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | — | $-5.4M | ||
| Q2 24 | — | $-6.5M | ||
| Q1 24 | — | $1.0M |
自由现金流率ASRTNOTE
| Q4 25 | — | -8.7% | ||
| Q3 25 | — | -46.2% | ||
| Q2 25 | — | -33.0% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | -11.4% | ||
| Q3 24 | — | -18.4% | ||
| Q2 24 | — | -22.1% | ||
| Q1 24 | — | 3.3% |
资本支出强度ASRTNOTE
| Q4 25 | — | 7.4% | ||
| Q3 25 | — | 9.3% | ||
| Q2 25 | — | 6.4% | ||
| Q1 25 | — | 7.2% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | 0.0% | 8.3% | ||
| Q2 24 | — | 9.4% | ||
| Q1 24 | — | 5.3% |
现金转化率ASRTNOTE
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
NOTE
| Subscription | $21.2M | 95% |
| Advisory Advertising And Other | $1.0M | 5% |
